Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Karel H van der Pol"'
Autor:
Karel H van der Pol, Jan Koenderink, Jeroen J M W van den Heuvel, Petra van den Broek, Janny Peters, Imke D W van Bunningen, Jeanne Pertijs, Frans G M Russel, Jim Koldenhof, Wim J Morshuis, Joris van Drongelen, Tom J J Schirris, Andries van der Meer, Gerard A Rongen
Publikováno v:
PLoS ONE, Vol 19, Iss 6, p e0305906 (2024)
Uric acid induces radical oxygen species formation, endothelial inflammation, and endothelial dysfunction which contributes to the progression of atherosclerosis. Febuxostat inhibits BCRP- and allopurinol stimulates MRP4-mediated uric acid efflux in
Externí odkaz:
https://doaj.org/article/fd27e0ee1021449984bd8991649ed5a0
Allopurinol to reduce cardiovascular morbidity and mortality: A systematic review and meta-analysis.
Autor:
Karel H van der Pol, Kimberley E Wever, Mariette Verbakel, Frank L J Visseren, Jan H Cornel, Gerard A Rongen
Publikováno v:
PLoS ONE, Vol 16, Iss 12, p e0260844 (2021)
AimsTo compare the effectiveness of allopurinol with no treatment or placebo for the prevention of cardiovascular events in hyperuricemic patients.Methods and resultsPubmed, Web of Science and Cochrane library were searched from inception until July
Externí odkaz:
https://doaj.org/article/4677bfc6c5724f919b034d4faf8c67aa
Autor:
Karel H. van der Pol, Marga Nijenhuis, Bianca Soree, Nienke J. de Boer-Veger, Anne Marie Buunk, Henk-Jan Guchelaar, Arne Risselada, Ron H. N. van Schaik, Jesse J. Swen, Daan Touw, Jan van der Weide, Roos van Westrhenen, Vera H. M. Deneer, Elisa J. F. Houwink, Gerard A. Rongen
Publikováno v:
European Journal of Human Genetics. Nature Publishing Group
European Journal of Human Genetics. SPRINGERNATURE
European Journal of Human Genetics
European Journal of Human Genetics. SPRINGERNATURE
European Journal of Human Genetics
The Dutch Pharmacogenetics Working Group (DPWG) aims to facilitate PGx implementation by developing evidence-based pharmacogenetics guidelines to optimize pharmacotherapy. This guideline describes the gene-drug interaction of ABCG2 with allopurinol,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6cec37152e6fc9e7daaa1ea1275fd4f
https://hdl.handle.net/1887/3458834
https://hdl.handle.net/1887/3458834
Autor:
Frank L.J. Visseren, Gerard A. Rongen, Karel H van der Pol, Mariette Verbakel, Jan H. Cornel, Kimberley E. Wever
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 12, p e0260844 (2021)
PLoS One, 16, 12
PLoS One, 16
PLoS ONE, Vol 16, Iss 12, p e0260844 (2021)
PLoS One, 16, 12
PLoS One, 16
Aims To compare the effectiveness of allopurinol with no treatment or placebo for the prevention of cardiovascular events in hyperuricemic patients. Methods and results Pubmed, Web of Science and Cochrane library were searched from inception until Ju